Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Lung Yu

Showing results (81-90 of 616) with videos related to

Pageof 62
Sort By:
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 26, 2025
HCV elimination in hyperendemic areas: Experiences in TaiwanChia-Yen Dai, Chung-Feng Huang, Wan-Long Chuang, et al.
The Journal of Infectious Diseases|September 13, 2023
HCV Microelimination for High-risk Special PopulationsChung-Feng Huang, Guan-Jhou Chen, Chien-Ching Hung, et al.
Hepatic Medicine : Evidence and Research|August 27, 2025
MAFLD: A Comprehensive Review of the Link Between Metabolic Dysfunction and Cardiovascular RiskAlaa M Mostafa, Ziyan Pan, Ming-Lung Yu, et al.
The American Journal of Gastroenterology|September 4, 2009
The substantial role of initial ribavirin dose on the response to peginterferon alpha/ribavirin therapy in patients with genotype 1b chronic hepatitis CChia-Yen Dai, Chung-Feng Huang, Wan-Long Chuang, et al.
Gut|March 9, 2010
Insulin resistance, viral load and response to peginterferon and ribavirin in patients with chronic hepatitis C virus infectionChia-Yen Dai, Jee-Fu Huang, Ming-Yen Hsieh, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2005
Successful treatment of fulminant hepatitis C by therapy with alpha interferon and ribavirinMing-Lung Yu, Nai-Jen Hou, Chia-Yen Dai, et al.
Journal of Food and Drug Analysis|September 16, 2017
Acute pancreatitis in patients with type 2 diabetes mellitus treated with dipeptidyl peptidase-4 inhibitorsTzu-Lin Yang, Mei-Chiou Shen, Ming-Lung Yu, et al.
Hepatology (Baltimore, Md.)|April 26, 2008
Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: Some issuesMing-Lung Yu, Chia-Yen Dai, Jee-Fu Huang, et al.
Diabetes Care|May 30, 2008
Abnormal liver function test predicts type 2 diabetes: a community-based prospective study: response to Cho et alJee-Fu Huang, Chia-Yen Dai, Ming-Lung Yu, et al.
Travel Medicine and Infectious Disease|August 11, 2022
Pretravel preparation and factors associated with willingness to seek pretravel consultation among Taiwanese travelers: Some concernsChia-Yen Dai, Ming-Lung Yu, Hung-Yi Chuang, et al.
Pageof 62

Showing results (81-90 of 616) with videos related to

Sort By:
Pageof 62
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 26, 2025
HCV elimination in hyperendemic areas: Experiences in TaiwanChia-Yen Dai, Chung-Feng Huang, Wan-Long Chuang, et al.
The Journal of Infectious Diseases|September 13, 2023
HCV Microelimination for High-risk Special PopulationsChung-Feng Huang, Guan-Jhou Chen, Chien-Ching Hung, et al.
Hepatic Medicine : Evidence and Research|August 27, 2025
MAFLD: A Comprehensive Review of the Link Between Metabolic Dysfunction and Cardiovascular RiskAlaa M Mostafa, Ziyan Pan, Ming-Lung Yu, et al.
The American Journal of Gastroenterology|September 4, 2009
The substantial role of initial ribavirin dose on the response to peginterferon alpha/ribavirin therapy in patients with genotype 1b chronic hepatitis CChia-Yen Dai, Chung-Feng Huang, Wan-Long Chuang, et al.
Gut|March 9, 2010
Insulin resistance, viral load and response to peginterferon and ribavirin in patients with chronic hepatitis C virus infectionChia-Yen Dai, Jee-Fu Huang, Ming-Yen Hsieh, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2005
Successful treatment of fulminant hepatitis C by therapy with alpha interferon and ribavirinMing-Lung Yu, Nai-Jen Hou, Chia-Yen Dai, et al.
Journal of Food and Drug Analysis|September 16, 2017
Acute pancreatitis in patients with type 2 diabetes mellitus treated with dipeptidyl peptidase-4 inhibitorsTzu-Lin Yang, Mei-Chiou Shen, Ming-Lung Yu, et al.
Hepatology (Baltimore, Md.)|April 26, 2008
Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: Some issuesMing-Lung Yu, Chia-Yen Dai, Jee-Fu Huang, et al.
Diabetes Care|May 30, 2008
Abnormal liver function test predicts type 2 diabetes: a community-based prospective study: response to Cho et alJee-Fu Huang, Chia-Yen Dai, Ming-Lung Yu, et al.
Travel Medicine and Infectious Disease|August 11, 2022
Pretravel preparation and factors associated with willingness to seek pretravel consultation among Taiwanese travelers: Some concernsChia-Yen Dai, Ming-Lung Yu, Hung-Yi Chuang, et al.
Pageof 62